Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$217.21 USD
-0.34 (-0.16%)
Updated May 24, 2024 04:00 PM ET
After-Market: $217.18 -0.03 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Charles River Laboratories International, Inc. [CRL]
Reports for Purchase
Showing records 301 - 320 ( 381 total )
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Operating Margins Soften but Meaningful Improvement Expected in 2H19; Raising PT
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Focus Turns to Citoxlab Deal Following 2018''s Strong Finish
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
CRL announced plans to integrate the Atomwise artificial intelligence (AI) drug discovery software into its discovery research services
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Investing for the Future; Raising PT to $140
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Research Summary
Provider: KEYBANC CAPITAL MARKETS